David A Horne

This inventor holds 63 USPTO granted patents and 18 published patent applications and 8 EPO patents, primarily in Cancer Treatments (CPC class A61K). Top assignees: Beckman Research Institute, City of Hope, University of California, Columbia University. Active years: 1998-2026.

USPTO Granted Patents = 63 (Patent Applications = 18)

% Patents Active = 95.2

EPO Patents = 8 (Patent Applications = 14)

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 171(Granted Patents)

Forward Citations (Not Self Cited) = 115(Dec 10, 2025)

Inventors with similar research interests:

Location History:

New York, NY (US) (1998 - 2003)
Los Angeles, CA (US) (2019)
Duarte, CA (US) (2014 - 2023)
Altadena, CA (US) (2009 - 2024)

Company Filing History:

55 out of 692

Beckman Research Institute, City of Hope

patents

6 out of 15,964

University of California

California Institute of Technology

patents

5. 3 out of 7

National and Kapodistrian University of Athens

University of Southern California

patents

8. 2 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

PCNA Inhibitors

DNA2 Inhibitors

Chimeric Antigen Receptor

Cancer Treatment

T-Cell Lymphoma

Ribonucleotide Reductase

Adipocyte Modulators

Wnt Signaling Inhibitors

Therapeutic Compounds

Berbamine Derivatives

Isatin Derivatives

5-Bromo-Indirubins

63 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12714753 - MEDITOPES AND MEDITOPE-BINDING ANTIBODIES AND USES THEREOF (2026-08-25),

2. 12617845 - SMC1A ANTIBODIES AND USES THEREOF (2026-05-05),

3. 12565658 - CD33 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FOR TREATMENT OF CD33 POSITIVE MALIGNANCIES (2026-03-03),

4. 12486275 - Substituted pyrazino[2,1-c][1,2,4]triazines as Wnt/CBP/catenin signaling pathway inhibitors (2025-12-02),

5. 12435030 - PCNA inhibitors (2025-10-07),

6. 12173000 - Berbamine derivatives and methods of use thereof (2024-12-24),

7. 12054447 - PCNA inhibitors (2024-08-06),

8. 11974993 - Solution formulations of CX-011 (2024-05-07),

9. 11964941 - 5-Bromo-indirubins (2024-04-23),

10. 11897952 - Mechanically interlocking complexes (2024-02-13),

11. 11858879 - PARG inhibitors and method of use thereof (2024-01-02),

12. 11780815 - DNA2 inhibitors for cancer treatment (2023-10-10),

13. 11766442 - T-cell lymphoma treatments (2023-09-26),

14. 11759530 - TKI permeability enhancers (2023-09-19),

15. 11584760 - Dithio ETP derivatives (2023-02-21),

Title: The Innovative Mind of David A. Horne

Introduction: David A. Horne is a distinguished inventor based in Duarte, California. With a passion for creating groundbreaking solutions, he has made significant contributions to the field of technology through his inventive spirit and dedication.

Latest Patents: David A. Horne holds several patents in various technological domains, showcasing his versatility and ingenuity in developing novel ideas that push the boundaries of innovation.

Career Highlights: Throughout his illustrious career, David A. Horne has been recognized for his pioneering work in the tech industry. His innovative approach to problem-solving has led to the development of cutting-edge solutions that have had a lasting impact on the field.

Collaborations: David A. Horne has collaborated with leading tech companies and research institutions to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: David A. Horne's relentless pursuit of innovation and his commitment to pushing the limits of what is possible make him a true visionary in the world of technology. His contributions continue to inspire the next generation of inventors and shape the future of technological advancements.